-
Je něco špatně v tomto záznamu ?
QRS micro-fragmentation as a mortality predictor
K. Hnatkova, I. Andršová, T. Novotný, A. Britton, M. Shipley, B. Vandenberk, DJ. Sprenkeler, J. Junttila, T. Reichlin, S. Schlögl, MA. Vos, T. Friede, A. Bauer, HV. Huikuri, R. Willems, G. Schmidt, MR. Franz, C. Sticherling, M. Zabel, M. Malik
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
MR/M006638/1
Medical Research Council - United Kingdom
NH/16/2/32499
British Heart Foundation - United Kingdom
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
- MeSH
- elektrokardiografie * metody MeSH
- lidé MeSH
- prediktivní hodnota testů MeSH
- prognóza MeSH
- rizikové faktory MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
AIMS: Fragmented QRS complex with visible notching on standard 12-lead electrocardiogram (ECG) is understood to represent depolarization abnormalities and to signify risk of cardiac events. Depolarization abnormalities with similar prognostic implications likely exist beyond visual recognition but no technology is presently suitable for quantification of such invisible ECG abnormalities. We present such a technology. METHODS AND RESULTS: A signal processing method projects all ECG leads of the QRS complex into optimized three perpendicular dimensions, reconstructs the ECG back from this three-dimensional projection, and quantifies the difference (QRS 'micro'-fragmentation, QRS-μf) between the original and reconstructed signals. QRS 'micro'-fragmentation was assessed in three different populations: cardiac patients with automatic implantable cardioverter-defibrillators, cardiac patients with severe abnormalities, and general public. The predictive value of QRS-μf for mortality was investigated both univariably and in multivariable comparisons with other risk factors including visible QRS 'macro'-fragmentation, QRS-Mf. The analysis was made in a total of 7779 subjects of whom 504 have not survived the first 5 years of follow-up. In all three populations, QRS-μf was strongly predictive of survival (P < 0.001 univariably, and P < 0.001 to P = 0.024 in multivariable regression analyses). A similar strong association with outcome was found when dichotomizing QRS-μf prospectively at 3.5%. When QRS-μf was used in multivariable analyses, QRS-Mf and QRS duration lost their predictive value. CONCLUSION: In three populations with different clinical characteristics, QRS-μf was a powerful mortality risk factor independent of several previously established risk indices. Electrophysiologic abnormalities that contribute to increased QRS-μf values are likely responsible for the predictive power of visible QRS-Mf.
Department of Cardiology and Pneumology University Medical Center Göttingen Germany
Department of Cardiology Inselspital Bern University Hospital Bern Switzerland
Department of Cardiology University Hospital of Basel Basel Switzerland
Department of Cardiovascular Sciences University of Leuven Leuven Belgium
Department of Internal Medicine and Cardiology Masaryk University Brno Czech Republic
Department of Internal Medicine and Cardiology University Hospital Brno Brno Czech Republic
Department of Medical Physiology University Medical Center Utrecht Utrecht The Netherlands
Department of Medical Statistics University Medical Center Göttingen Göttingen Germany
German Center for Cardiovascular Research Partner Site Munich Heart Alliance Munich Germany
German Center of Cardiovascular Research Partner Site Göttingen Göttingen Germany
Klinikum rechts der Isar Technical University of Munich Munich Germany
Medical Research Center Oulu University Central Hospital of Oulu and University of Oulu Oulu Finland
Research Department of Epidemiology and Public Health University College London UK
University Hospital for Internal Medicine 3 Medical University Innsbruck Innsbruck Austria
Veteran Affairs and Georgetown University Medical Centers Washington DC USA
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22033014
- 003
- CZ-PrNML
- 005
- 20230131151055.0
- 007
- ta
- 008
- 230120s2022 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/eurheartj/ehac085 $2 doi
- 035 __
- $a (PubMed)35187560
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hnatkova, Katerina $u National Heart and Lung Institute, Imperial College, ICTEM, Hammersmith Campus, 72 Du Cane Road, Shepherd's Bush, London W12 0NN, UK $1 https://orcid.org/0000000201591610
- 245 10
- $a QRS micro-fragmentation as a mortality predictor / $c K. Hnatkova, I. Andršová, T. Novotný, A. Britton, M. Shipley, B. Vandenberk, DJ. Sprenkeler, J. Junttila, T. Reichlin, S. Schlögl, MA. Vos, T. Friede, A. Bauer, HV. Huikuri, R. Willems, G. Schmidt, MR. Franz, C. Sticherling, M. Zabel, M. Malik
- 520 9_
- $a AIMS: Fragmented QRS complex with visible notching on standard 12-lead electrocardiogram (ECG) is understood to represent depolarization abnormalities and to signify risk of cardiac events. Depolarization abnormalities with similar prognostic implications likely exist beyond visual recognition but no technology is presently suitable for quantification of such invisible ECG abnormalities. We present such a technology. METHODS AND RESULTS: A signal processing method projects all ECG leads of the QRS complex into optimized three perpendicular dimensions, reconstructs the ECG back from this three-dimensional projection, and quantifies the difference (QRS 'micro'-fragmentation, QRS-μf) between the original and reconstructed signals. QRS 'micro'-fragmentation was assessed in three different populations: cardiac patients with automatic implantable cardioverter-defibrillators, cardiac patients with severe abnormalities, and general public. The predictive value of QRS-μf for mortality was investigated both univariably and in multivariable comparisons with other risk factors including visible QRS 'macro'-fragmentation, QRS-Mf. The analysis was made in a total of 7779 subjects of whom 504 have not survived the first 5 years of follow-up. In all three populations, QRS-μf was strongly predictive of survival (P < 0.001 univariably, and P < 0.001 to P = 0.024 in multivariable regression analyses). A similar strong association with outcome was found when dichotomizing QRS-μf prospectively at 3.5%. When QRS-μf was used in multivariable analyses, QRS-Mf and QRS duration lost their predictive value. CONCLUSION: In three populations with different clinical characteristics, QRS-μf was a powerful mortality risk factor independent of several previously established risk indices. Electrophysiologic abnormalities that contribute to increased QRS-μf values are likely responsible for the predictive power of visible QRS-Mf.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a elektrokardiografie $x metody $7 D004562
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Andršová, Irena $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine and Cardiology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000189735967
- 700 1_
- $a Novotný, Tomáš $u Department of Internal Medicine and Cardiology, University Hospital Brno, Brno, Czech Republic $u Department of Internal Medicine and Cardiology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000202924034
- 700 1_
- $a Britton, Annie $u Research Department of Epidemiology and Public Health, University College London, UK
- 700 1_
- $a Shipley, Martin $u Research Department of Epidemiology and Public Health, University College London, UK
- 700 1_
- $a Vandenberk, Bert $u Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium $1 https://orcid.org/000000018296920X
- 700 1_
- $a Sprenkeler, David J $u Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands $1 https://orcid.org/000000031572280X
- 700 1_
- $a Junttila, Juhani $u Medical Research Center Oulu, University Central Hospital of Oulu and University of Oulu, Oulu, Finland $1 https://orcid.org/0000000288961281
- 700 1_
- $a Reichlin, Tobias $u Department of Cardiology, Inselspital, Bern University Hospital, Bern, Switzerland $1 https://orcid.org/0000000271978415
- 700 1_
- $a Schlögl, Simon $u Department of Cardiology and Pneumology, University Medical Center, Göttingen, Germany $u German Center of Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany
- 700 1_
- $a Vos, Marc A $u Department of Medical Physiology, University Medical Center Utrecht, Utrecht, The Netherlands
- 700 1_
- $a Friede, Tim $u German Center of Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany $u Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0000000153477441
- 700 1_
- $a Bauer, Axel $u University Hospital for Internal Medicine III, Medical University Innsbruck, Innsbruck, Austria $1 https://orcid.org/0000000192018555
- 700 1_
- $a Huikuri, Heikki V $u Medical Research Center Oulu, University Central Hospital of Oulu and University of Oulu, Oulu, Finland
- 700 1_
- $a Willems, Rik $u Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium $1 https://orcid.org/0000000254699609
- 700 1_
- $a Schmidt, Georg $u Klinikum rechts der Isar, Technical University of Munich, Munich, Germany $u German Center for Cardiovascular Research Partner Site Munich Heart Alliance, Munich, Germany $1 https://orcid.org/0000000336925243
- 700 1_
- $a Franz, Michael R $u Veteran Affairs and Georgetown University Medical Centers, Washington, DC, USA
- 700 1_
- $a Sticherling, Christian $u Department of Cardiology, University Hospital of Basel, Basel, Switzerland $1 https://orcid.org/0000000184287050
- 700 1_
- $a Zabel, Markus $u Department of Cardiology and Pneumology, University Medical Center, Göttingen, Germany $u German Center of Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany $1 https://orcid.org/0000000308954602
- 700 1_
- $a Malik, Marek $u National Heart and Lung Institute, Imperial College, ICTEM, Hammersmith Campus, 72 Du Cane Road, Shepherd's Bush, London W12 0NN, UK $u Department of Internal Medicine and Cardiology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000237921407
- 773 0_
- $w MED00009622 $t European heart journal $x 1522-9645 $g Roč. 43, č. 40 (2022), s. 4177-4191
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35187560 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151051 $b ABA008
- 999 __
- $a ok $b bmc $g 1891652 $s 1184349
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 43 $c 40 $d 4177-4191 $e 2022Oct21 $i 1522-9645 $m European heart journal $n Eur Heart J $x MED00009622
- GRA __
- $a MR/M006638/1 $p Medical Research Council $2 United Kingdom
- GRA __
- $a NH/16/2/32499 $p British Heart Foundation $2 United Kingdom
- LZP __
- $a Pubmed-20230120